1. Home
  2. RITM vs KRYS Comparison

RITM vs KRYS Comparison

Compare RITM & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

HOLD

Current Price

$11.96

Market Cap

6.5B

Sector

Real Estate

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$290.17

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RITM
KRYS
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RITM
KRYS
Price
$11.96
$290.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
10
Target Price
$14.22
$244.20
AVG Volume (30 Days)
8.0M
294.0K
Earning Date
01-30-2026
02-18-2026
Dividend Yield
8.51%
N/A
EPS Growth
46.96
275.72
EPS
1.45
6.66
Revenue
$3,961,432,000.00
$373,164,000.00
Revenue This Year
N/A
$36.14
Revenue Next Year
$7.71
$42.38
P/E Ratio
$8.10
$42.93
Revenue Growth
32.03
54.51
52 Week Low
$9.13
$122.80
52 Week High
$12.74
$295.98

Technical Indicators

Market Signals
Indicator
RITM
KRYS
Relative Strength Index (RSI) 67.33 70.73
Support Level $11.05 $271.52
Resistance Level $11.81 $295.98
Average True Range (ATR) 0.25 12.15
MACD 0.07 1.53
Stochastic Oscillator 92.15 89.63

Price Performance

Historical Comparison
RITM
KRYS

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: